José Pablo Suárez Llanos

Introduction: Malnutrition and sarcopenia are frequent in advanced lung cancer, worsening outcomes and quality of life. Early detection and intervention are essential. This study assessed the effectiveness of R-MAPP in detecting malnutrition and sarcopenia risk compared to standard clinical practice. Material and methods: A prospective, randomized, multicenter study of 65 advanced lung cancer patients assigned to R-MAPP or standard care was performed. R-MAPP integrates MUST and SARC-F with clinical data. Outcomes included risk identification, weight, quality of life (EQ-5D-5L), and handgrip strength. Analyses were adjusted for baseline imbalances (alcohol use, chemotherapy). Results: The R-MAPP group identified 42.4% of patients at risk vs. 3.1% in the control group (p < 0.001). After adjustment, R-MAPP markedly increased the likelihood of detecting at-risk patients (adjusted OR = 21.2, 95% CI: 2.6–175.4, p = 0.005). No significant differences were observed in weight (4.94 kg, 95% CI: –4.59–14.48, p = 0.30) or quality of life (–8.45 VAS points, 95% CI: –22.62–5.71, p = 0.23), although both remained stable despite a higher chemotherapy rate in the intervention group. Conclusions: R-MAPP effectively identifies patients at risk of malnutrition and sarcopenia in advanced lung cancer, supporting early intervention in complex clinical settings. Although further studies are needed to assess its long-term impact and diagnostic performance, R-MAPP is a practical, efficient tool for risk screening rather than diagnostic confirmation in routine oncology care. However, as this was a pilot study without a formal sample size calculation, secondary outcomes should be interpreted as exploratory only. This also applies to the wide confidence interval observed for the primary outcome.

Introduction: Malnutrition is a well-established negative prognostic factor in hospitalized patients, contributing to increased morbidity and mortality. The CIPA (Control of Food Intake, Protein, and Anthropometry) screening tool was developed to identify patients at nutritional risk and to predict adverse clinical outcomes across both surgical and non-surgical populations. This study aimed to evaluate the prognostic value of the CIPA tool in routine clinical practice by analyzing its association with key clinical outcomes since its implementation at our center in 2014.Materials and methods: We conducted a retrospective analysis of inpatients screened with the CIPA tool between 2014 and 2022 in a tertiary care hospital. The association between CIPA screening results and clinical outcomes—including 3- and 6-month mortality, early hospital readmission, and length of stay—was assessed, with a particular focus on patients with active oncological disease. Regression analyses were adjusted for age, sex, admitting department, and type of admission.Results: A total of 30,581 patients were included, of whom 31.4% screened positive for malnutrition using the CIPA tool. CIPA-positive patients had significantly higher mortality at 3 months (adjusted OR 3.02; 95% CI: 2.78–3.30; p < 0.001) and at 6 months (adjusted OR 2.69; 95% CI: 2.49–2.91; p < 0.001). They also exhibited increased rates of early readmission (adjusted OR 1.43; 95% CI: 1.34–1.53; p < 0.001) and a longer median hospital stay (β = 0.25; 95% CI: 0.23–0.27; p < 0.001).Discussion: In this large, real-world cohort, the CIPA nutritional screening tool was a robust predictor of poorer clinical outcomes among hospitalized patients with positive screening results. These findings support the utility of CIPA screening for early identification of high-risk patients, enabling targeted nutritional interventions to potentially mitigate adverse outcomes.

Background: Hospital malnutrition has high prevalence and is associated with worse clinical outcomes. The lack of standardized nutritional screening prompted the creation of the CIPA screening tool. Several studies have shown that the phase angle (PA) is associated with increased nutritional risk and worse clinical outcomes. The aim of this study was to establish the concordance between the CIPA and GLIM criteria and to assess their correlation with PA values and clinical outcomes. Methods: A cross-sectional single-center study was carried out, with a prospective six-month follow-up for the prognostic variables. On admission, the CIPA and GLIM criteria and bioimpedanciometry were assessed. Results: A total of 510 inpatients were included; 36.5% had positive CIPA outcomes and 46.1% had positive GLIM outcomes. The correlation between the CIPA and GLIM criteria had a kappa index of 0.26, p < 0.01. Those with positive CIPA had a higher mortality risk (OR = 1.81) and longer mean length of stay (MLS) (OR = 1.45). The PA cut-off points were determined by sex and age for CIPA (men > 65 years: 4.75°, men ≤ 65 years: 5.75°, women > 65 years: 4.75°, and women ≤ 65 years: 5.45°) and GLIM (men > 65 years: 4.95°, men ≤ 65 years: 5.85°, women > 65 years: 4.75°, and women ≤ 65 years: 5.55°). These PA cut-off points were associated with worse clinical outcomes with CIPA (mortality OR = 4.2; MLS OR = 1.51; readmissions OR = 2.28) and GLIM (mortality OR = 2.97; MLS OR = 2.61; readmissions OR = 1.79). Conclusions: CIPA screening shows a low correlation with GLIM nutritional assessment. Positive CIPA and GLIM have lower PAs than negative and worse prognostic outcomes. The PA cut-off points associated with worse outcomes have been established.

(1) Background: Hospital malnutrition and sarcopenia are common in inpatients and are associated with worse prognosis. Our objective is to determine the association of the positivity of CIPA (Control of Intakes, Proteins and Anthropometry) nutrition screening tool and sarcopenia and evaluate its prognostic implications (length of stay, readmissions and mortality) as well as different components of body composition. (2) Methodology: Cross-sectional single-center study and prospective six months follow-up for prognostic variables. On admission, CIPA and EWGSOP2 criteria were assessed. (3) Results: Four hundred inpatients, a median of 65.71 years old and 83.6% with high comorbidity, were evaluated. In total, 34.8% had positive CIPA and 19.3% sarcopenia. Positive CIPA and sarcopenia had worse results in body composition (fat mass (FM), fat-free mass (FFM) and appendicular skeletal muscle mass index (ASMI)) and dynamometry. Positive CIPA is significantly associated with worse prognosis (mortality (OR = 1.99), readmissions (OR = 1.86) and length of stay (B = 0.19)). Positive CIPA and sarcopenia combined are associated with a tendency to higher mortality (OR = 2.1, p = 0.088). Low hand grip strength (HGS) is significantly related to a higher length of stay (B = −0.12). (4) Conclusions: In hospitalized patients, malnutrition independently and combined with sarcopenia is associated with a worse prognosis but not body composition. Low HGS is related to a higher length of stay.

Revista oficial de la Sociedad Española de Nutrición Parenteral y de la Sociedad Española de Nutrición. Está dedicada al estudio y divulgación de temas relacionados con la nutrición.

Malnutrition has a multifactorial origin and can be caused by cancer. This study determined the consensus of a panel of experts on the nutritional approach for cancer patients in Spain using a multidisciplinary approach. Using the Delphi methodology, a 74-question questionnaire was prepared and sent to 46 experts. The areas of knowledge addressed were the nutritional status of the cancer patient, nutritional screening, nutritional therapy, patient referral, and multidisciplinary care. A total of 91.7% of the experts agreed with the questions posed on nutritional status, 60.0% with those on nutritional screening, 76.7% with those on nutritional therapy, and the entire panel of experts agreed with the questions posed on patient referral and multidisciplinary care. The experts agreed upon a high prevalence of malnutrition among cancer patients in Spain. Unlike medical and radiation oncologists, medical nutrition specialists believe that body composition assessment should not be carried out in all types of cancer patients during nutritional screening and that interventions can be conducted outside the oncology clinic. In general, it is recommended that nursing staff routinely perform nutritional screening before starting cancer treatment. It is necessary to develop a multidisciplinary action protocol that includes nutritional and/or sarcopenia screening.

Introduction Hospital malnutrition is very common and worsens the clinical course of patients while increasing costs. Lacking clinical-economic studies on the implementation of nutrition screening encouraged the evaluation of the CIPA (Control of Food Intake, Protein, Anthropometry) tool....

Malnutrition is prevalent in surgical patients and leads to comorbidities and a poorer postoperative course. There are no studies that compare the clinical outcomes of implementing a nutrition screening tool in surgical patients with standard clinical practice. An open, non-randomized, controlled study was conducted in general and digestive surgical hospitalized patients, who were either assigned to standard clinical care or to nutrition screening using the Control of Food Intake, Protein, and Anthropometry (CIPA) tool and an associated treatment protocol (n = 210 and 202, respectively). Length of stay, mortality, readmissions, in-hospital complications, transfers to critical care units, and reinterventions were evaluated. Patients in the CIPA group had a higher Charlson index on admission and underwent more oncological and hepatobiliary-pancreatic surgeries. Although not significant, a shorter mean length of stay was observed in the CIPA group (−1.48 days; p < 0.246). There were also fewer cases of exitus (seven vs. one) and fewer transfers to critical care units in this group (p = 0.068 for both). No differences were detected in other clinical variables. In conclusion, patients subjected to CIPA nutrition screening and treatment showed better clinical outcomes than those receiving usual clinical care. The results were not statistically significant, possibly due to the heterogeneity across patient groups.

Introduction : There is no gold-standard method for hospital nutrition screening. The new screening tool termed Control of Food Intake, Protein, and Anthropometry (CIPA) gives positive results when at least one of the following parameters is met: control of food intake for 72 h Material and...